Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Massachusetts General Hospital
Boston, United States
Harvard University
Cambridge, United States
Mayo Clinic in Arizona
Scottsdale, United States
Mayo Clinic
Rochester, United States
Manchester Academic Health Science Centre
Manchester, United Kingdom
RWTH Aachen University
Aachen, Germany
Universitätsklinikum Aachen
Aachen, Germany
University of Milan
Milan, Italy
Zhongda Hospital Southeast University
Nanjing, China
Erasmus MC
Rotterdam, The Netherlands
References
References (91)
- 1
Calciphylaxis: from the disease to the diseased.
Oliveira TM, Frazão JM
Journal of nephrology 2015; (28(5)):531-40 doi:10.1007/s40620-015-0192-2.
PMID: 25835730 - 2
The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
Floege J, Kubo Y, Floege A, et al.
Clinical journal of the American Society of Nephrology : CJASN 2015; (10(5)):800-7 doi:10.2215/CJN.10221014.
PMID: 25887067 - 3
Calciphylaxis: risk factors, diagnosis, and treatment.
Nigwekar SU, Kroshinsky D, Nazarian RM, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2015; (66(1)):133-46.
PMID: 25960299 - 4
Penile lesion in end-stage renal failure - cancer or otherwise?: Calcific uremic arteriolopathy presenting with a penile lesion.
Malthouse T, Lam W, Brewin J, et al.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2015; (9(3-4)):136-7 doi:10.5489/cuaj.2331.
PMID: 26085872 - 5
Raman spectroscopy for label-free identification of calciphylaxis.
Lloyd WR, Agarwal S, Nigwekar SU, et al.
Journal of biomedical optics 2015; (20(8)):80501 doi:10.1117/1.JBO.20.8.080501.
PMID: 26263412 - 6
Multidisciplinary approach to calcific uremic arteriolopathy.
Nigwekar SU
Current opinion in nephrology and hypertension 2015; (24(6)):531-7 doi:10.1097/MNH.0000000000000175.
PMID: 26371529 - 7
Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis.
Malbos S, Ureña-Torres P, Bardin T, Ea HK
Joint bone spine 2016; (83(1)):89-92.
PMID: 26494591 - 8
Calciphylaxis: a case series and the role of radiology in diagnosis.
Bonchak JG, Park KK, Vethanayagamony T, et al.
International journal of dermatology 2016; (55(5)):e275-9 doi:10.1111/ijd.13043.
PMID: 26518613 - 9
Gastrointestinal Bleeding Secondary to Calciphylaxis.
Gupta N, Haq KF, Mahajan S, et al.
The American journal of case reports 2015; (16()):818-22 doi:10.12659/ajcr.895164.
PMID: 26572938 - 10
Warfarin and Vascular Calcification.
Poterucha TJ, Goldhaber SZ
The American journal of medicine 2016; (129(6)):635.e1-4.
PMID: 26714212 - 11
Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.
Brandenburg VM, Kramann R, Rothe H, et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017; (32(1)):126-132 doi:10.1093/ndt/gfv438.
PMID: 26908770 - 12
Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?
Brandenburg VM, Evenepoel P, Floege J, et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016; (31(8)):1211-9 doi:10.1093/ndt/gfw025.
PMID: 27005994 - 13
Calciphylaxis of the Breast: A Case Report and Literature Review.
Hall DJ, Gentile LF, Duckworth LV, et al.
The breast journal 2016; (22(5)):568-72 doi:10.1111/tbj.12632.
PMID: 27332900 - 14
Calciphylaxis in peritoneal dialysis patients: a single center cohort study.
Zhang Y, Corapi KM, Luongo M, et al.
International journal of nephrology and renovascular disease 2016; (9()):235-241 doi:10.2147/IJNRD.S115701.
PMID: 27698566 - 15
Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis.
McCarthy JT, El-Azhary RA, Patzelt MT, et al.
Mayo Clinic proceedings 2016; (91(10)):1384-1394 doi:10.1016/j.mayocp.2016.06.025.
PMID: 27712637 - 16
Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis.
Nigwekar SU, Bloch DB, Nazarian RM, et al.
Journal of the American Society of Nephrology : JASN 2017; (28(6)):1717-1722 doi:10.1681/ASN.2016060651.
PMID: 28049648 - 17
Warfarin-Associated Nonuremic Calciphylaxis.
Yu WY, Bhutani T, Kornik R, et al.
JAMA dermatology 2017; (153(3)):309-314 doi:10.1001/jamadermatol.2016.4821.
PMID: 28099971 - 18
Calciphylaxis.
Nigwekar SU
Current opinion in nephrology and hypertension 2017; (26(4)):276-281 doi:10.1097/MNH.0000000000000328.
PMID: 28375870 - 19
Early clinical presentations and progression of calciphylaxis.
Ghosh T, Winchester DS, Davis MDP, et al.
International journal of dermatology 2017; (56(8)):856-861 doi:10.1111/ijd.13622.
PMID: 28436018 - 20
The Role of Bone Scintigraphy with Single-photon Emission Computed Tomography-computed Tomography in the Diagnosis and Evaluation of Calciphylaxis.
Martineau P, Pelletier-Galarneau M, Bazarjani S
World journal of nuclear medicine 2017; (16(2)):172-174 doi:10.4103/1450-1147.203076.
PMID: 28553189 - 21
Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review.
Riemer CA, El-Azhary RA, Wu KL, et al.
The British journal of dermatology 2017; (177(6)):1510-1518 doi:10.1111/bjd.15702.
PMID: 28580642 - 22
Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients.
Peng T, Zhuo L, Wang Y, et al.
Nephrology (Carlton, Vic.) 2018; (23(7)):669-675 doi:10.1111/nep.13081.
PMID: 28603903 - 23
Management of a Complex Peristomal Calciphylaxis: A Case Study.
Famorca M, Beauchaine D, Angulo N
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society 2017; (44(4)):380-383 doi:10.1097/WON.0000000000000343.
PMID: 28682855 - 24
Extraosseous Calcification of the Esophagus: Clinicopathologic Correlates of Esophageal Mucosal Calcinosis.
Garber A, Arora Z, Welch N, et al.
ACG case reports journal 2017; (4()):e108 doi:10.14309/crj.2017.108.
PMID: 28932755 - 25
Histopathology of Calciphylaxis: Cohort Study With Clinical Correlations.
Chen TY, Lehman JS, Gibson LE, et al.
The American Journal of dermatopathology 2017; (39(11)):795-802 doi:10.1097/DAD.0000000000000824.
PMID: 29053546 - 26
Calciphylaxis after parathyroidectomy.
Karmegam S, Shetty A
Hemodialysis international. International Symposium on Home Hemodialysis 2017; (21 Suppl 2()):S62-S66 doi:10.1111/hdi.12599.
PMID: 29064176 - 27
[Calcific uremic arteriolopathy (calciphylaxis) : update in 2018].
Alves C, Ernandez T, Stoermann Chopard C
Revue medicale suisse 2018; (14(595)):426-429.
PMID: 29465875 - 28
Calciphylaxis in end-stage liver and renal disease patients before and after transplant.
Couri T, Stier M, Mikolajczyk A, Aronsohn A
Clinical transplantation 2018; (32(6)):e13272 doi:10.1111/ctr.13272.
PMID: 29714030 - 29
An Update on Calciphylaxis.
García-Lozano JA, Ocampo-Candiani J, Martínez-Cabriales SA, Garza-Rodríguez V
American journal of clinical dermatology 2018; (19(4)):599-608 doi:10.1007/s40257-018-0361-x.
PMID: 29808451 - 30
A case report of pediatric calciphylaxis-a rare and potentially fatal under diagnosed condition.
Stârcea M, Gavrilovici C, Elsayed A, et al.
Medicine 2018; (97(27)):e11300 doi:10.1097/MD.0000000000011300.
PMID: 29979398 - 31
The Role of Matrix Gla Protein (MGP) in Vascular Calcification.
Bjørklund G, Svanberg E, Dadar M, et al.
Current medicinal chemistry 2020; (27(10)):1647-1660 doi:10.2174/0929867325666180716104159.
PMID: 30009696 - 32
Metabolic acidosis after sodium thiosulfate infusion and the role of hydrogen sulfide.
Hunt GM, Ryder HF
Clinical case reports 2018; (6(8)):1595-1599 doi:10.1002/ccr3.1673.
PMID: 30147912 - 33
Factors associated with false-negative pathologic diagnosis of calciphylaxis.
Williams EA, Moy AP, Cipriani NA, et al.
Journal of cutaneous pathology 2019; (46(1)):16-25 doi:10.1111/cup.13364.
PMID: 30280393 - 34
Management of Penile Calciphylaxis: A Case Study.
Zillioux JM, Geisenhoff A, Gray M
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society 2018; (45(6)):536-539 doi:10.1097/WON.0000000000000483.
PMID: 30395130 - 35
Calciphylaxis in patients with chronic kidney disease: A disease which is still bewildering and potentially fatal.
Cucchiari D, Torregrosa JV
Nefrologia 2018; (38(6)):579-586 doi:10.1016/j.nefro.2018.05.007.
PMID: 30415999 - 36
A Rare Case of Multiorgan Calciphylaxis in a Patient with Stage 5 Chronic Kidney Disease.
Ahmad A, Albaghli A, Michael A, et al.
Case reports in urology 2018; (2018()):9603680 doi:10.1155/2018/9603680.
PMID: 30420934 - 37
Calciphylaxis-as a drug induced adverse event.
Portales-Castillo I, Kroshinsky D, Malhotra CK, et al.
Expert opinion on drug safety 2019; (18(1)):29-35 doi:10.1080/14740338.2019.1559813.
PMID: 30574812 - 38
The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: A comprehensive review.
Deen J, Schaider H
The Australasian journal of dermatology 2019; (60(3)):e186-e194 doi:10.1111/ajd.12992.
PMID: 30666627 - 39
Revisiting therapeutic options for calciphylaxis.
Seethapathy H, Nigwekar SU
Current opinion in nephrology and hypertension 2019; (28(5)):448-454 doi:10.1097/MNH.0000000000000520.
PMID: 31169527 - 40
Clinicopathologic Features and Calcium Deposition Patterns in Calciphylaxis: Comparison With Gangrene, Peripheral Artery Disease, Chronic Stasis, and Thrombotic Vasculopathy.
McMullen ER, Harms PW, Lowe L, et al.
The American journal of surgical pathology 2019; (43(9)):1273-1281 doi:10.1097/PAS.0000000000001302.
PMID: 31192861 - 41
Correlation between clinical and pathological features of cutaneous calciphylaxis.
Dutta P, Chaudet KM, Nazarian RM, et al.
PloS one 2019; (14(6)):e0218155 doi:10.1371/journal.pone.0218155.
PMID: 31194797 - 42
Calciphylaxis After Kidney Transplant.
Ryan MP, Ross LS
Cureus 2019; (11(5)):e4695 doi:10.7759/cureus.4695.
PMID: 31338270 - 43
[The nightmare of calciphylaxis].
Ulrich M, Götz M, Krah X
Aktuelle Urologie 2021; (52(1)):70-72 doi:10.1055/a-0892-1899.
PMID: 31344746 - 44
Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.
Gaisne R, Péré M, Menoyo V, et al.
BMC nephrology 2020; (21(1)):63 doi:10.1186/s12882-020-01722-y.
PMID: 32101140 - 45
Hyperbaric oxygen therapy in patients suffering from wounds in calciphylaxis: a narrative review.
Charaghvandi DA, Teguh DN, van Hulst RA
Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2020; (47(1)):111-123 doi:10.22462/01.03.2020.12.
PMID: 32176952 - 46
Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein.
Roumeliotis S, Dounousi E, Salmas M, et al.
Frontiers in medicine 2020; (7()):154 doi:10.3389/fmed.2020.00154.
PMID: 32391368 - 47
Diagnosing Calciphylaxis: A Review With Emphasis on Histopathology.
Bahrani E, Perkins IU, North JP
The American Journal of dermatopathology 2020; (42(7)):471-480 doi:10.1097/DAD.0000000000001526.
PMID: 32604207 - 48
Isolated Mesenteric Calciphylaxis With Ischemic Colitis in a Hemodialysis Patient Without Active Cutaneous Calciphylaxis: A Case Report of Calcific Uremic Arteriolopathy.
Tan RYP, Juneja R, Gunawardane DN, Milton CA
Kidney medicine 2020; (2(2)):209-212 doi:10.1016/j.xkme.2019.12.005.
PMID: 32734240 - 49
Calciphylaxis - Case Report.
Prohic N, Masnic F, Fazlic MK, et al.
Medical archives (Sarajevo, Bosnia and Herzegovina) 2020; (74(3)):233-235 doi:10.5455/medarh.2020.74.233-235.
PMID: 32801442 - 50
Management of Cutaneous Calciphylaxis.
Kodumudi V, Jeha GM, Mydlo N, Kaye AD
Advances in therapy 2020; (37(12)):4797-4807 doi:10.1007/s12325-020-01504-w.
PMID: 32997277 - 51
Risk factors for calciphylaxis in Chinese hemodialysis patients: a matched case-control study.
Liu Y, Zhang X, Xie X, et al.
Renal failure 2021; (43(1)):406-416 doi:10.1080/0886022X.2021.1884094.
PMID: 33641601 - 52
Clinical mimickers of calciphylaxis: A retrospective study.
Gabel CK, Blum AE, François J, et al.
Journal of the American Academy of Dermatology 2021; (85(6)):1520-1527 doi:10.1016/j.jaad.2021.03.035.
PMID: 33744358 - 53
The Multifactorial Pathogenesis of Calciphylaxis: A Case Report.
Turek M, Stępniewska J, Różański J
The American journal of case reports 2021; (22()):e930026 doi:10.12659/AJCR.930026.
PMID: 34097671 - 54
Successful Treatment of Calciphylaxis in a Young Female With End-Stage Renal Disease on Peritoneal Dialysis With Parathyroidectomy, Intensification of Dialysis, and Sodium Thiosulphate-A Case Report and Literature Review.
Roy S, Reddy SN, Garcha AS, et al.
Journal of investigative medicine high impact case reports 2021; (9()):23247096211060580 doi:10.1177/23247096211060580.
PMID: 34845938 - 55
Manifestation of Nonuremic Calciphylaxis in the Extremities: Case Report and Review.
Zulauf EE, Connors JC, Hardy MA
The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 2022; (61(5)):e41-e47 doi:10.1053/j.jfas.2021.10.024.
PMID: 34876341 - 56
Prevalence and Clinical Characteristics of Calciphylaxis in Chinese Hemodialysis Patients.
Liu Y, Yang C, Yang X, et al.
Frontiers in medicine 2022; (9()):902171 doi:10.3389/fmed.2022.902171.
PMID: 35755071 - 57
Calciphylaxis and Kidney Disease: A Review.
Gallo Marin B, Aghagoli G, Hu SL, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2023; (81(2)):232-239 doi:10.1053/j.ajkd.2022.06.011.
PMID: 35970430 - 58
Perioperative Management of Calciphylaxis: Literature Review and Treatment Recommendations.
Strand N, Maloney J, Wu S, et al.
Orthopedic reviews 2022; (14(3)):37573 doi:10.52965/001c.37573.
PMID: 36034726 - 59
Characterization of Risk Factors for Calciphylaxis in Hemodialysis Patients in the Fraser Health Renal Program - A Matched Case-Control Retrospective Review.
Jang A, Mark Ho MH, Yan L
Journal of pharmacy practice 2023; (36(6)):1424-1437 doi:10.1177/08971900221118444.
PMID: 36036088 - 60
Patient-Reported and Clinical Outcomes Among Patients With Calciphylaxis.
Wen W, Krinsky S, Kroshinsky D, et al.
Mayo Clinic proceedings. Innovations, quality & outcomes 2023; (7(1)):81-92 doi:10.1016/j.mayocpiqo.2022.12.006.
PMID: 36712824 - 61
Clinical features and outcomes of calciphylaxis in Chinese patients with chronic kidney disease.
Jiao Y, Sun L, Xie X, et al.
Nephrology (Carlton, Vic.) 2023; (28(6)):305-314 doi:10.1111/nep.14156.
PMID: 36883928 - 62
Intravenous Sodium Thiosulphate for Calciphylaxis of Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Wen W, Portales-Castillo I, Seethapathy R, et al.
JAMA network open 2023; (6(4)):e2310068 doi:10.1001/jamanetworkopen.2023.10068.
PMID: 37099293 - 63
Profound metabolic acidosis in association with sodium thiosulfate therapy in a patient with calcific uremic arteriolopathy: a case report and literature review.
Abdalla M, Faris ME, Saad E, et al.
CEN case reports 2024; (13(1)):59-65 doi:10.1007/s13730-023-00801-x.
PMID: 37273129 - 64
The application of MDT model for calciphylaxis management in patients with end-stage renal disease.
Pan Y, Wang H, Ye Y, et al.
International wound journal 2023; (20(9)):3717-3723 doi:10.1111/iwj.14265.
PMID: 37309083 - 65
Calciphylaxis, A Case Series: The Importance of Early Detection.
Sijapati N, Fong SSH, Ansari O, et al.
HCA healthcare journal of medicine 2023; (4(1)):43-49 doi:10.36518/2689-0216.1214.
PMID: 37426565 - 66
A retrospective review of outcomes after hyperbaric oxygen therapy for the treatment of calciphylaxis.
Biglione B, Cucka B, Iriarte C, et al.
Journal of the American Academy of Dermatology 2024; (90(1)):45-51 doi:10.1016/j.jaad.2023.07.1031.
PMID: 37586460 - 67
Multimodality approach to treat calciphylaxis in end-stage kidney disease patients.
Lajoie C, Ghanemi A, Bourbeau K, et al.
Renal failure 2023; (45(2)):2256413 doi:10.1080/0886022X.2023.2256413.
PMID: 37724534 - 68
Calcific Uremic Arteriolopathy in End-Stage Renal Disease: A Rare Life-Threatening Condition.
Okan T, Ghuman K, Chaudhary F, et al.
Cureus 2023; (15(10)):e48002 doi:10.7759/cureus.48002.
PMID: 38034199 - 69
Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.
Yousuf S, Busch D, Renner R, et al.
Renal failure 2024; (46(1)):2297566 doi:10.1080/0886022X.2023.2297566.
PMID: 38178572 - 70
Occlusive cutaneous vasculopathies as cause of chronic ulcers.
Ronicke M, Berking C, Erfurt-Berge C
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2024; (22(4)):553-567 doi:10.1111/ddg.15276.
PMID: 38379266 - 71
Penile Calciphylaxis: A Successfully Treated Case.
Misakyan N, Abu-Shanab A, Shah S
Cureus 2024; (16(2)):e54824 doi:10.7759/cureus.54824.
PMID: 38529436 - 72
Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study.
Tan AJ, Xia J, Glennon CM, et al.
Journal of the American Academy of Dermatology 2024; (91(5)):834-842 doi:10.1016/j.jaad.2024.06.058.
PMID: 38972479 - 73
Advanced Calciphylaxis in a Patient With End-Stage Renal Disease: A Case Report Highlighting Diagnostic and Therapeutic Challenges in Late-Stage Presentation.
Chaganlal PP, Kalandoor V, Jones DT, et al.
Cureus 2024; (16(9)):e68866 doi:10.7759/cureus.68866.
PMID: 39246637 - 74
Penile Calciphylaxis Obscured by Phimosis in an End-Stage Renal Disease Patient: A Case Report.
Angammana CU, Fernando H, Silva F
Cureus 2024; (16(8)):e67156 doi:10.7759/cureus.67156.
PMID: 39295658 - 75
Risk Factors Associated With the Development of Calciphylaxis in Patients With Chronic Kidney Disease: A Systematic Review.
Ogah CO, Mohammed H, Gabra IM, et al.
Cureus 2024; (16(12)):e75314 doi:10.7759/cureus.75314.
PMID: 39776750 - 76
Livedoid vasculopathy, calciphylaxis, and Martorell's hypertensive ulcer: update on ischemic ulcers due to impaired microcirculation of the lower limbs.
Lacerda PN, Garcia LC, Mazeto IFDS, et al.
Anais brasileiros de dermatologia 2025; (100(2)):215-227 doi:10.1016/j.abd.2024.09.004.
PMID: 39848831 - 77
Calciphylaxis: ongoing challenges and treatment opportunities with mesenchymal stem cells.
Wu D, Lu S, Hu J, et al.
Journal of molecular cell biology 2025; (17(2)) doi:10.1093/jmcb/mjaf009.
PMID: 40097288 - 78
Calciphylaxis Penile Lesion: An Unusual Complication of End-Stage Renal Disease.
Grote J, Geyer-Roberts E, Banuelos A, et al.
Cureus 2025; (17(3)):e80625 doi:10.7759/cureus.80625.
PMID: 40230779 - 79
Calciphylaxis of the Upper Limbs-A Rare and Serious Disease with Multidisciplinary Treatments-A Case Series and Literature Review.
Pertea M, Benamor M, Bulgaru-Iliescu AI, et al.
Diagnostics (Basel, Switzerland) 2025; (15(9)) doi:10.3390/diagnostics15091179.
PMID: 40361997 - 80
Calciphylaxis: A Rare Manifestation of a Common Disease.
Nancassa C, Baiherych T, Figueiredo A
Cureus 2025; (17(5)):e84550 doi:10.7759/cureus.84550.
PMID: 40546520 - 81
Buprenorphine for the Management of Intractable Pain in Skin Ulcers Associated With Calcific Uremic Arteriolopathy.
Whitfield S, Pellecer DS
Pain medicine case reports 2024; (8(6)):223-227.
PMID: 40577429 - 82
Ten tips on how to deal with calciphylaxis patients.
Chewcharat A, Nigwekar SU
Clinical kidney journal 2025; (18(4)):sfaf098 doi:10.1093/ckj/sfaf098.
PMID: 40600068 - 83
Elevated Perioperative Morbidity After Parathyroidectomy for Calciphylaxis Patients: A Nationwide Retrospective Observational Study.
Bauzon J, Perez-Soto R, Jin J, et al.
The Journal of surgical research 2025; (314()):185-190 doi:10.1016/j.jss.2025.07.011.
PMID: 40768885 - 84
A Case Report of Non-Uremic Calciphylaxis Refractory to Treatment Requiring Multidisciplinary Care.
Lee R, Kahn H, Aiad M, Wilson M
Case reports in dermatology 2025; (17(1)):471-477 doi:10.1159/000547832.
PMID: 41059361 - 85
Calciphylaxis diagnosis, management and future directions: a comprehensive update on behalf of the European Renal Association CKD-MBD Working Group.
Huish S, Moore S, Alfieri C, et al.
Clinical kidney journal 2025; (18(12)):sfaf338 doi:10.1093/ckj/sfaf338.
PMID: 41367922 - 86
Navigating Calciphylaxis in End-Stage Renal Disease: A Case Report Highlighting the Complexities of Pain Control and the Need for Greater Clinical Vigilance.
Lau RCN, Whitwell BL, Chinawanitkit C, Ahmed F
Cureus 2025; (17(11)):e96962 doi:10.7759/cureus.96962.
PMID: 41409958 - 87
Calciphylaxis in the Upper GI Tract in an ESRD Patient: An Atypical Presentation and Review of Literature.
D Shirsat P, Sonavane K, Botana LR, Sachdeva B
Case reports in nephrology 2025; (2025()):3967671 doi:10.1155/crin/3967671.
PMID: 41472909 - 88
Calciphylaxis in a patient with end-stage renal disease: Multimodality imaging and clinical correlation.
Zaki C, Stevens KJ
Radiology case reports 2026; (21(3)):1255-1260 doi:10.1016/j.radcr.2025.11.024.
PMID: 41536868 - 89
Lived experiences of patients with calciphylaxis (CALCI-E): a qualitative study.
Huish S, Bingham C, Treadgold BM, Sinha S
Journal of nephrology 2026; (39(2)):381-389 doi:10.1093/joneph/aajaf017.
PMID: 41837776 - 90
Calciphylaxis Mimicry in End-Stage Renal Disease: Acute Limb Ischemia From Calcific Peripheral Arterial Disease.
Izadian Bidgoli A, Isayan E, Buryk Y, et al.
Cureus 2026; (18(5)):e109854 doi:10.7759/cureus.109854.
PMID: 42375920 - 91
Calciphylaxis in chronic kidney disease: a systematic review of pathomechanisms and risk factors for calcific uremic arteriolopathy.
Søndergaard C, Nagarajah S, Shen J, et al.
Renal failure 2026; (48(1)):2710397 doi:10.1080/0886022X.2026.2710397.
PMID: 42572798